Expert Interview
A Second Look: Understanding the impact of 6 reported cases of inflammation in patients receiving Syfovre injections
Ticker(s): APLS, ISEEInstitution: UC Davis
- Associate Professor of Medicine and retina specialist at UC Davis.
- Manages hundreds of patients with wet-AMD and 50 patients with Geographic atrophy; treats all forms of medical and surgical diseases of the retina.
- Research focus on retinal cell replacement and gene therapy approaches for photoreceptor diseases; special interest and focus in the diagnosis and management of inherited retinal diseases.
Please describe your background and practice setting
Added By: ben_adminHow many patients with geographic atrophy do you manage?
Added By: ben_adminHave you prescribed Syfovre? If so, have any patients experienced inflammation?
Added By: ben_adminWhat impact does the 6 cases of inflammation have on your prescribing habits of Syfovre moving forward?
Added By: ben_adminWhat rate of occlusive retinal vasculitis is acceptable in your mind for these patients?
Added By: ben_adminHow likely is it in your view that all 6 cases were the result of Syfovre's mechanism of action versus some other cause?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
